Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
STAT+: For this cancer-focused digital health startup, an FDA rejection meant the end of the road
STAT October 17, 2024
Blue Note’s failure holds lessons for other digital therapeutics startups
The bad news didn’t come all at once for Blue Note Therapeutics, but a final denial from the Food and Drug Administration in January proved to be the final blow.
In late 2023, after a rejection from the agency earlier in the year, Blue Note had made a last...
Today's Sponsors
Today's Sponsor